New Non-Contact laser could make glaucoma treatment easier

NCT ID NCT07408154

Recruiting now Disease control Sponsor: Medical University of South Carolina Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study compares two FDA-approved laser treatments for open-angle glaucoma: the standard SLT and a newer, non-contact version called DSLT. Both aim to lower eye pressure and prevent vision loss. About 172 adults with glaucoma or high eye pressure will be randomly assigned to one treatment and followed for 12 months to see which is safer and more effective.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: laser treatment (Direct Selective Laser Trabeculoplasty or Selective Laser Trabeculoplasty)
What this could lead to: If DSLT works as well as or better than standard SLT, it could offer a more comfortable and efficient way to lower eye pressure and prevent vision loss in glaucoma patients.
What could go wrong: This is a relatively small, early-stage comparison. The newer DSLT may not prove superior or could have unexpected side effects. Results may not apply to all glaucoma types.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for EXFOLIATIVE GLAUCOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

exfoliation syndrome glaucoma ocular hypertension open-angle glaucoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

OCULAR HYPERTENSION (OHT) OPEN-ANGLE GLAUCOMA (OAG)

Contacts and locations

Locations

MUSC
RECRUITING

Charleston, South Carolina, 29407, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.